West Pharmaceutical Shuttering Montgomery, Pennsylvania, Plant
12/07/2010
"The changing landscapes in the healthcare and consumer markets we serve require that we regularly evaluate our operations and adapt to changing conditions in order to successfully compete," said Donald E. Morel Jr., West's chairman and CEO. "The plans announced today will reduce the manufacturing capacity devoted to product lines that no longer support sustainable, competitive operations. These are difficult decisions that fall most heavily on our employees in these locations, and we will be providing support that should ease the burden placed on them."
The facility produced molded plastic components and assemblies for consumer products.
Project Announcements
Eurofins Lancaster Laboratories Expands Lancaster County, Pennsylvania, Research Operations
01/03/2026
Creative 3D Technologies Expands Cedar Park, Texas, Headquarters-Manufacturing Operations
01/03/2026
Valerie Health Plans Chattanooga, Tennessee, Operations
01/02/2026
Samsung Biologics Plans Rockville, Maryland, Manufacturing Operations
12/31/2025
Kraken Technologies Limited Plans New York City Headquarters Operations
12/29/2025
Lupin Expands Coral Springs, Florida, Operations
12/29/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025
-
Supply Chain Whiplash Reshapes CRE
Q3 2025